Skip to main content
Erschienen in: Supportive Care in Cancer 11/2006

01.11.2006 | Short Communication

Gastrostomies in palliative care

verfasst von: Ferraz Gonçalves, Mónica Mozes, Isabel Saraiva, Cristina Ramos

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2006

Einloggen, um Zugang zu erhalten

Abstract

Objective

In palliative care, gastrostomies are used to provide nutritional support or to decompress the bowel. To evaluate what happened to the patients monitored at our palliative care unit (PCU) who underwent gastrostomy between October 1994 and January 2005, a retrospective audit was made.

Method

The charts of 154 patients were reviewed.

Results

The most frequent reason why a patient underwent a gastrostomy was dysphagia due to head and neck and/or esophageal cancer. Only one patient underwent a drainage gastrostomy because of intestinal obstruction. Interventional radiology performed 96% of the gastrostomies. Early complications occurred in 53 patients (34%) who underwent the gastrostomy for feeding and the most common was local pain, usually mild. However, there was one death due to peritonitis, probably related with the procedure. Late complications also occurred in 53 patients and major complications occurred in 22 patients, the most common was extrusion. The median survival after the performance of the gastrostomy was 61 days (range 1 to 551 days). Nineteen patients (12%) survived 1 week or less, 28 (18%) between 8 and 30 days, 51 (33%) from 31 to 90 days, 53 (35%) 91 days or more, and one unknown. The patient who underwent a gastrostomy for bowel obstruction survived for only 7 days. One hundred and twenty-five patients (81%) died at the PCU, 26 (17%) at home, and four (3%) at other places.
Literatur
1.
Zurück zum Zitat Walker LG (1984) L. L. Straton MD, and the first successful gastrostomy in America. Surg Gynecol Obstet 158:387–388PubMed Walker LG (1984) L. L. Straton MD, and the first successful gastrostomy in America. Surg Gynecol Obstet 158:387–388PubMed
2.
Zurück zum Zitat Wollman B, D’Agostino HB, Walus-Wigle JR, Easter DW, Beale A (1995) Radiologic, endoscopic, and surgical gastrostomy: an institutional evaluation and meta-analysis of the literature. Radiology 197:699–704PubMed Wollman B, D’Agostino HB, Walus-Wigle JR, Easter DW, Beale A (1995) Radiologic, endoscopic, and surgical gastrostomy: an institutional evaluation and meta-analysis of the literature. Radiology 197:699–704PubMed
3.
Zurück zum Zitat Preshaw RM (1981) A percutaneous method for inserting a feeding gastrostomy tube. Surg Gynecol Obstet 152:659–660 Preshaw RM (1981) A percutaneous method for inserting a feeding gastrostomy tube. Surg Gynecol Obstet 152:659–660
4.
Zurück zum Zitat Ferraz Gonçalves JAS (2001) A Portuguese palliative care unit. Support Care Cancer 9:4–7CrossRef Ferraz Gonçalves JAS (2001) A Portuguese palliative care unit. Support Care Cancer 9:4–7CrossRef
5.
Zurück zum Zitat Mercadante S (1998) Parenteral versus enteral nutrition in cancer patients: indications and practice. Support Care Cancer 6:85–93CrossRefPubMed Mercadante S (1998) Parenteral versus enteral nutrition in cancer patients: indications and practice. Support Care Cancer 6:85–93CrossRefPubMed
6.
Zurück zum Zitat Waitzberg DL, Plopper C, Terra RM (2000) Access route for nutritional therapy. World J Surg 24:1468–1476CrossRefPubMed Waitzberg DL, Plopper C, Terra RM (2000) Access route for nutritional therapy. World J Surg 24:1468–1476CrossRefPubMed
7.
Zurück zum Zitat Magné N, Marcy PY, Foa C, Falewee MN, Schneider M, Demard F, Bensadoun RJ (2001) Comparison between nasogastric tube feeding and percutaneous fluoroscopic gastrostomy in advanced head and neck cancer patients. Eur Arch Otorhinolaryngol 258:89–92CrossRefPubMed Magné N, Marcy PY, Foa C, Falewee MN, Schneider M, Demard F, Bensadoun RJ (2001) Comparison between nasogastric tube feeding and percutaneous fluoroscopic gastrostomy in advanced head and neck cancer patients. Eur Arch Otorhinolaryngol 258:89–92CrossRefPubMed
8.
Zurück zum Zitat Park RHR, Allison MC, Lang J et al (1992) Randomised comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients with persisting neurological dysphagia. BMJ 304:1406–1409PubMedCrossRef Park RHR, Allison MC, Lang J et al (1992) Randomised comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients with persisting neurological dysphagia. BMJ 304:1406–1409PubMedCrossRef
9.
Zurück zum Zitat Hull MA, Rawlings J, Murray FE et al (1993) Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomy. Lancet 341:869–872CrossRefPubMed Hull MA, Rawlings J, Murray FE et al (1993) Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomy. Lancet 341:869–872CrossRefPubMed
10.
Zurück zum Zitat Hunter JG, Lauretano L, Shellito PC (1989) Percutaneous endoscopic gastrostomy in head and neck cancer patients. Ann Surg 210:42–46CrossRefPubMed Hunter JG, Lauretano L, Shellito PC (1989) Percutaneous endoscopic gastrostomy in head and neck cancer patients. Ann Surg 210:42–46CrossRefPubMed
11.
Zurück zum Zitat Malone JM, Koonce T, Larson DM, Freedman RS, Carrasco CHO, Saul PB (1986) Palliation of small bowel obstruction by percutaneous gastrostomy in patients with progressive ovarian carcinoma. Obstet Gynecol 68:431–433PubMed Malone JM, Koonce T, Larson DM, Freedman RS, Carrasco CHO, Saul PB (1986) Palliation of small bowel obstruction by percutaneous gastrostomy in patients with progressive ovarian carcinoma. Obstet Gynecol 68:431–433PubMed
12.
Zurück zum Zitat O’Keeffe F, Carrasco CH, Charnsangajev C, Richli WR, Wallace S, Freedman RS (1989) Percutaneous drainage and feeding gastrostomies in 100 patients. Radiology 172:341–343PubMed O’Keeffe F, Carrasco CH, Charnsangajev C, Richli WR, Wallace S, Freedman RS (1989) Percutaneous drainage and feeding gastrostomies in 100 patients. Radiology 172:341–343PubMed
13.
Zurück zum Zitat Scheidbach H, Horbach T, Groitl H, Hohenberger W (1999) Percutaneous endoscopic gastrostomy/jejunostomy (PEG/PEJ) for decompression in the upper gastrointestinal tract. Surg Endosc 13:1103–1005CrossRef Scheidbach H, Horbach T, Groitl H, Hohenberger W (1999) Percutaneous endoscopic gastrostomy/jejunostomy (PEG/PEJ) for decompression in the upper gastrointestinal tract. Surg Endosc 13:1103–1005CrossRef
14.
Zurück zum Zitat Pothuri B, Montemarano M, Gerardi M et al (2005) Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Gynecol Oncol 96:330–334CrossRefPubMed Pothuri B, Montemarano M, Gerardi M et al (2005) Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Gynecol Oncol 96:330–334CrossRefPubMed
15.
Zurück zum Zitat Brooksbank MA, Game PA, Ashby MA (2002) Palliative venting gastrostomy in malignant intestinal obstruction. Palliat Med 16:520–526CrossRefPubMed Brooksbank MA, Game PA, Ashby MA (2002) Palliative venting gastrostomy in malignant intestinal obstruction. Palliat Med 16:520–526CrossRefPubMed
Metadaten
Titel
Gastrostomies in palliative care
verfasst von
Ferraz Gonçalves
Mónica Mozes
Isabel Saraiva
Cristina Ramos
Publikationsdatum
01.11.2006
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 11/2006
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0045-6

Weitere Artikel der Ausgabe 11/2006

Supportive Care in Cancer 11/2006 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.